What are the principles of chronic hepatitis B patient selection?

        For chronic hepatitis B patients, there is a lack of very effective drugs, so some patients "treatment", "sick, see a doctor" drug advertising or publicity in the treatment of liver diseases will buy to take, which also eat, eat it, the money is not cure the disease. This is not scientific. Patients with chronic hepatitis should have the following principles:

        (1) the use of drugs do not have too many miscellaneous: a lot of drugs have to go through the liver detoxification. Excessive use of drugs can increase the burden on the liver, but the liver disease. Some patients in the western medicine treatment, after a long period of illness, but more and more heavy, finally stopped all in western medicine, but illness improved, in general, each medication does not exceed 2-3, the course is not more than 2-3 months, such as invalid can be replaced by other drugs, or stop for a period of time, if available you can continue to apply.

        (2) in the process of drug use should not be ignored, rest, nutrition, etc.: body rest and nutrition is the main treatment of patients with liver diseases. As the saying goes "three partition seven minutes to raise", because the drug is limited, only on the basis to ensure the rest and nutrition that may play a role, ignoring the rest, nutrition, and simply blindly medication, you have the order reversed.

        (3) the application of bifendate, Qianglining or Ganli acid drugs such as often can be decreased or even normal transaminase, but does not mean that the disease has improved or cured, rebound phenomenon often occurs after the withdrawal of the drug, so in the application of these drugs to transaminase dropped to normal, as a kind of steroid tapering, and insist on taking 2-3 months or even a year.

        (4) according to the specific circumstances of patients, targeted drug use: for example, hepatitis B virus replication in patients using antiviral drugs significantly; drug application adjust the immune function of immune disorders; drug application protection of hepatocyte injury; drug application of active hepatic microcirculation microcirculation. Can also be based on syndrome differentiation taking prescription of traditional Chinese medicine, syndrome differentiation or selection of 1-2 Chinese medicine for long-term use.